Assessing Antimicrobial Resistance in Papillomavirus-Related Infections: A Comprehensive Review of Prevalence, Impact on Treatment Strategies, and Implications for Disease Control Efforts.

Antimicrobial resistance (AMR) is a growing global concern. Among these, papillomavirus-related infections, caused by human papillomavirus (HPV), have gained significant attention due to their association with cervical cancer and other clinical conditions The aim of this review is to address critical research questions concerning antimicrobial resistance in HPV infections by examining the current prevalence of AMR in papillomavirus-related infections. Databases and search engines used for literature retrieval included PubMed, Scopus and Web of Science. The review highlights the potential impact of AMR on the effectiveness of current treatment options. It addresses the potential consequences of AMR on prophylactic HPV vaccination programs, screening strategies, and disease control efforts. It has provided critical insights for informing evidence-based policies, prevention strategies, and novel approaches for tackling antimicrobial-resistant HPV infections. By understanding the dynamics of antimicrobial resistance in HPV infections, we can optimize clinical management strategies, safeguard public health, and improve global health outcomes .